0001144204-17-006572.txt : 20170207 0001144204-17-006572.hdr.sgml : 20170207 20170207210050 ACCESSION NUMBER: 0001144204-17-006572 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161208 FILED AS OF DATE: 20170207 DATE AS OF CHANGE: 20170207 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MusclePharm Corp CENTRAL INDEX KEY: 0001415684 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770664193 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4721 IRONTON STREET CITY: DENVER STATE: CO ZIP: 80239 BUSINESS PHONE: (800) 210-7369 MAIL ADDRESS: STREET 1: 4721 IRONTON STREET CITY: DENVER STATE: CO ZIP: 80239 FORMER COMPANY: FORMER CONFORMED NAME: Tone in Twenty DATE OF NAME CHANGE: 20071018 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Drexler Ryan Charles CENTRAL INDEX KEY: 0001648033 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-53166 FILM NUMBER: 17580726 MAIL ADDRESS: STREET 1: 525 CHALETTE DRIVE CITY: BEVERLY HILLS STATE: CA ZIP: 90201 4/A 1 v458667_4a.xml OWNERSHIP DOCUMENT X0306 4/A 2016-12-08 2016-12-12 0 0001415684 MusclePharm Corp MSLP 0001648033 Drexler Ryan Charles C/O MUSCLEPHARM CORPORATION 4721 IRONTON STREET, BUILDING A DENVER CO 80239 1 1 1 0 See Remarks. Common Stock 2016-12-08 4 A 0 200000 0.00 A 283434 D Common Stock 2017-01-01 4 A 0 350000 0.00 A 633434 D Common Stock 1499408 I See Footnote On December 8, 2016, Mr. Drexler was granted 200,000 shares of restricted stock pursuant to the Amended and Restated Executive Employment Agreement between MusclePharm Corporation and Mr. Drexler, dated November 18, 2016 (the "Employment Agreement"). On January 1, 2017, Mr. Drexler was granted 350,000 shares of restricted stock pursuant to the Employment Agreement (the "Second Issuance"). Each grant of restricted stock vests in full upon the first anniversary of its respective grant date. The original Form 4 erroneously reported that the Second Issuance occurred on December 8, 2016. This amendment is being filed to accurately reflect that the Second Issuance occurred on January 1, 2017. Represents shares of common stock held by Consac LLC ("Consac"). Mr. Drexler is the Chief Executive Officer of Consac and may be deemed to be the indirect beneficial owner (as that term is defined under Rule 13d-3 of the Securities Exchange Act) of the common stock that Consac beneficially owns. Mr. Drexler has the power to direct the voting and disposition of the Issuer's common stock that Consac beneficially owns. President, Chief Executive Officer and Chairman of the Board of Directors. /s/ Ryan Charles Drexler 2017-02-07